Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 158

    2.

    Surgical treatment of full-thickness macular holes using autologous serum.

    Wells JA, Gregor ZJ.

    Eye (Lond). 1996;10 ( Pt 5):593-9.PMID: 8977788 [PubMed - indexed for MEDLINE]Related articles

    3.

    Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes.

    Thompson JT, Glaser BM, Sjaarda RN, Murphy RP.

    Am J Ophthalmol. 1995 Jan;119(1):48-54.PMID: 7825689 [PubMed - indexed for MEDLINE]Related articles

    4.

    The results of vitreous surgery for chronic macular holes.

    Thompson JT, Sjaarda RN, Lansing MB.

    Retina. 1997;17(6):493-501.PMID: 9428011 [PubMed - indexed for MEDLINE]Related articles

    5.

    Autologous platelet concentrate as an adjunct in macular hole healing: a pilot study.

    Korobelnik JF, Hannouche D, Belayachi N, Branger M, Guez JE, Hoang-Xuan T.

    Ophthalmology. 1996 Apr;103(4):590-4.PMID: 8618757 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes.

    Lansing MB, Glaser BM, Liss H, Hanham A, Thompson JT, Sjaarda RN, Gordon AJ.

    Ophthalmology. 1993 Jun;100(6):868-71; discussion 871-2.PMID: 8510899 [PubMed - indexed for MEDLINE]Related articles

    7.

    Adjuvant methods in macular hole surgery: intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange.

    Blumenkranz MS, Ohana E, Shaikh S, Chang S, Coll G, Morse LS, De Bustros S.

    Ophthalmic Surg Lasers. 2001 May-Jun;32(3):198-207.PMID: 11371086 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2.

    Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A.

    Ophthalmology. 1994 Jul;101(7):1195-200.PMID: 8035983 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery.

    Thompson JT, Smiddy WE, Williams GA, Sjaarda RN, Flynn HW Jr, Margherio RR, Abrams GW.

    Ophthalmology. 1998 Apr;105(4):700-6.PMID: 9544645 [PubMed - indexed for MEDLINE]Related articles

    10.

    To posture or not to posture after macular hole surgery.

    Dhawahir-Scala FE, Maino A, Saha K, Mokashi AA, McLauchlan R, Charles S.

    Retina. 2008 Jan;28(1):60-5.PMID: 18185139 [PubMed - indexed for MEDLINE]Related articles

    11.

    [A preliminary observation on vitrectomy combined with autologous platelet concentrate for the treatment of idiopathic macular holes]

    Zhao M, Li X, Lü Y, Li C.

    Zhonghua Yan Ke Za Zhi. 1998 Jul;34(4):260-3, 16. Chinese. PMID: 11877202 [PubMed - indexed for MEDLINE]Related articles

    12.

    Vitrectomy, fluid-gas exchange and transforming growth factor--beta-2 for the treatment of traumatic macular holes.

    Rubin JS, Glaser BM, Thompson JT, Sjaarda RN, Pappas SS, Murphy RP.

    Ophthalmology. 1995 Dec;102(12):1840-5.PMID: 9098285 [PubMed - indexed for MEDLINE]Related articles

    13.

    Autologous platelets for macular hole surgery: the Sussex Eye Hospital experience.

    Vote BJ, Membrey WL, Casswell AG.

    Clin Experiment Ophthalmol. 2004 Oct;32(5):472-7.PMID: 15498057 [PubMed - indexed for MEDLINE]Related articles

    14.

    Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study.

    Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA.

    Ophthalmology. 1992 Jul;99(7):1162-72; discussion 1173.PMID: 1495798 [PubMed - indexed for MEDLINE]Related articles

    15.

    Full-thickness macular holes treated with vitrectomy and tissue glue.

    Tilanus MA, Deutman AF.

    Int Ophthalmol. 1994-1995;18(6):355-8.PMID: 7642336 [PubMed - indexed for MEDLINE]Related articles

    16.

    Silicone oil vs. gas for the treatment of full-thickness macular hole.

    Pertile G, Claes C.

    Bull Soc Belge Ophtalmol. 1999;274:31-6.PMID: 10670160 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group.

    Paques M, Chastang C, Mathis A, Sahel J, Massin P, Dosquet C, Korobelnik JF, Le Gargasson JF, Gaudric A.

    Ophthalmology. 1999 May;106(5):932-8.PMID: 10328392 [PubMed - indexed for MEDLINE]Related articles

    18.

    Surgical treatment of macular holes with multiple recurrences.

    Thompson JT, Sjaarda RN.

    Ophthalmology. 2000 Jun;107(6):1073-7.PMID: 10857825 [PubMed - indexed for MEDLINE]Related articles

    19.

    Visual and anatomical success with short-term macular tamponade and autologous platelet concentrate.

    Mulhern MG, Cullinane A, Cleary PE.

    Graefes Arch Clin Exp Ophthalmol. 2000 Jul;238(7):577-83.PMID: 10955659 [PubMed - indexed for MEDLINE]Related articles

    20.

    Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery.

    Kim SS, Smiddy WE, Feuer WJ, Shi W.

    Retina. 2008 Nov-Dec;28(10):1408-15.PMID: 18827734 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data